{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:09:36Z","timestamp":1784761776060,"version":"3.55.0"},"reference-count":132,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.revmed.2022.10.001","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T08:27:34Z","timestamp":1673598454000},"page":"112-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Uv\u00e9ites\u00a0sarco\u00efdosiques\u00a0: regards crois\u00e9s de l\u2019ophtalmologiste et de l\u2019interniste"],"prefix":"10.1016","volume":"44","author":[{"given":"P.","family":"S\u00e8ve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Jacquot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"El Jammal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Jamilloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kodjikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4791-9618","authenticated-orcid":false,"given":"S.","family":"Giorgiutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2022.10.001_bib0665","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1055\/s-0040-1710536","article-title":"Ocular sarcoidosis","volume":"41","author":"S\u00e8ve","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2022.10.001_bib0670","doi-asserted-by":"crossref","first-page":"1700991","DOI":"10.1183\/13993003.00991-2017","article-title":"Phenotypes of organ involvement in sarcoidosis","volume":"51","author":"Schupp","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2022.10.001_bib0675","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2022.10.001_bib0680","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.autrev.2014.04.001","article-title":"Sarcoidosis and uveitis","volume":"13","author":"Jamilloux","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2022.10.001_bib0685","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccm.2015.08.009","article-title":"Ocular sarcoidosis","volume":"36","author":"Pasadhika","year":"2015","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.revmed.2022.10.001_bib0690","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/bjo.84.1.110","article-title":"Ocular involvement in sarcoidosis","volume":"84","author":"Rothova","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0695","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/08820530802007382","article-title":"Neuro-ophthalmic sarcoidosis: the University of Iowa experience","volume":"23","author":"Koczman","year":"2008","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0700","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/archopht.125.12.1657","article-title":"Orbital and adnexal sarcoidosis","volume":"125","author":"Prabhakaran","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0705","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/IIO.0b013e3181571d65","article-title":"Neuro-ophthalmologic manifestations of sarcoidosis","volume":"47","author":"Braswell","year":"2007","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.revmed.2022.10.001_bib0710","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/j.lpm.2012.04.004","article-title":"Ocular sarcoidosis","volume":"41","author":"Bodaghi","year":"2012","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2022.10.001_bib0715","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ajo.2021.03.047","article-title":"Classification criteria for sarcoidosis-associated uveitis","volume":"228","author":"Standardization of Uveitis Nomenclature (SUN) Working Group","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0720","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1136\/bjophthalmol-2018-313356","article-title":"Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis","volume":"103","author":"Mochizuki","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0725","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/09273948.2017.1386791","article-title":"Clinical characteristics of ocular sarcoidosis: a population-based study 1976-2013","volume":"27","author":"Ungprasert","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2022.10.001_bib0730","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ophtha.2006.05.074","article-title":"Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis","volume":"114","author":"Evans","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2022.10.001_bib0735","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s00417-019-04415-x","article-title":"Ethnicity and association with ocular, systemic manifestations and prognosis in 194\u00a0patients with sarcoid uveitis","volume":"257","author":"Coulon","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0740","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","article-title":"A focus on the epidemiology of uveitis","volume":"26","author":"Tsirouki","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"issue":"9","key":"10.1016\/j.revmed.2022.10.001_bib0745","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00417-019-04411-1","article-title":"Clinical and etiologic characteristics of de novo uveitis in patients aged 60\u00a0years and above: experience of a French tertiary center","volume":"257","author":"Grumet","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"issue":"1","key":"10.1016\/j.revmed.2022.10.001_bib0750","first-page":"133","article-title":"Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990\u00a0consecutive cases","volume":"38","author":"Luca","year":"2018","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0755","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/08820538.2021.1885721","article-title":"Epidemiology of uveitis in a tertiary care centre in Portugal","volume":"36","author":"Hermann","year":"2021","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0760","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2147\/OPTH.S80972","article-title":"Epidemiology of uveitis in the mid-Atlantic United States","volume":"9","author":"Bajwa","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0765","doi-asserted-by":"crossref","first-page":"102351","DOI":"10.1016\/j.autrev.2019.102351","article-title":"Uveitis: autoimmunity\u2026 and beyond","volume":"18","author":"Bertrand","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2022.10.001_bib0770","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/aos.14130","article-title":"Epidemiology of uveitis in a region of southern Sweden","volume":"98","author":"Bro","year":"2020","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.revmed.2022.10.001_bib0775","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/157340561501181207091552","article-title":"FDG-PET imaging in sarcoidosis","volume":"15","author":"Tana","year":"2019","journal-title":"Curr Med Imaging Rev."},{"key":"10.1016\/j.revmed.2022.10.001_bib0780","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ajo.2018.09.013","article-title":"Sarcoidosis-related uveitis: clinical presentation, disease course, and rates of systemic disease progression after uveitis diagnosis","volume":"198","author":"Ma","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0785","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/bjophthalmol-2016-309767","article-title":"Long-term visual and systemic prognoses of 83\u00a0cases of biopsy-proven sarcoid uveitis","volume":"101","author":"Rochepeau","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0790","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ajo.2021.03.003","article-title":"Systemic associations of sarcoid uveitis: correlation with uveitis phenotype and ethnicity","volume":"229","author":"Niederer","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0795","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00153496","article-title":"Risk factors for ocular sarcoidosis","volume":"72","author":"Rothova","year":"1989","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0800","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/bjophthalmol-2014-306353","article-title":"Clinical features and diagnostic evaluation of 83\u00a0biopsy-proven sarcoid uveitis cases","volume":"99","author":"Febvay","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0805","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ajo.2022.06.001","article-title":"Identification of multidimensional phenotypes using cluster analysis in sarcoid uveitis patients","volume":"242","author":"Fermon","year":"2022","journal-title":"Am J Ophthalmol."},{"issue":"12","key":"10.1016\/j.revmed.2022.10.001_bib0810","doi-asserted-by":"crossref","first-page":"E3894","DOI":"10.3390\/jcm9123894","article-title":"Factors associated with ocular and extraocular recovery in 143\u00a0patients with sarcoid uveitis","volume":"9","author":"Bienvenu","year":"2020","journal-title":"J Clin Med."},{"key":"10.1016\/j.revmed.2022.10.001_bib0815","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.3390\/jcm10102146","article-title":"Cardiac sarcoidosis is uncommon in patients with isolated sarcoid uveitis: outcome of 294\u00a0cases","volume":"10","author":"Richard","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.revmed.2022.10.001_bib0820","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ophtha.2015.01.003","article-title":"Sarcoidosis in the national veteran population: association of ocular inflammation and mortality","volume":"122","author":"Birnbaum","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2022.10.001_bib0825","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2022.10.001_bib0830","first-page":"1","article-title":"Prevalence of positive QuantiFERON-TB Test among sarcoid uveitis patients and its clinical implications in a country non endemic for tuberculosis","volume":"7","author":"Garneret","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.revmed.2022.10.001_bib0835","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/09273948.2015.1115082","article-title":"High resolution chest computerized tomography in the diagnosis of ocular sarcoidosis in a high TB endemic population","volume":"25","author":"Babu","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2022.10.001_bib0840","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12886-016-0194-4","article-title":"The serum angiotensin converting enzyme and lysozyme levels in patients with ocular involvement of autoimmune and infectious diseases","volume":"16","author":"Sahin","year":"2016","journal-title":"BMC Ophthalmol"},{"issue":"10","key":"10.1016\/j.revmed.2022.10.001_bib0845","first-page":"15716","article-title":"Comparative evaluation of 18FDG PET and 67Ga scintigraphy in patients with sarcoidosis","volume":"47","author":"Nishiyama","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.revmed.2022.10.001_bib0850","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.revmed.2022.10.001_bib0855","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3390\/cells10040766","article-title":"Sarcoidosis: a clinical overview from symptoms to diagnosis","volume":"10","author":"S\u00e8ve","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.revmed.2022.10.001_bib0860","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1055\/s-2002-36518","article-title":"Ocular manifestations of sarcoidosis","volume":"23","author":"Bradley","year":"2002","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2022.10.001_bib0865","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13023-017-0638-9","article-title":"Intermediate uveitis: pattern of etiology, complications, treatment and outcome in a tertiary academic center","volume":"12","author":"Ness","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.revmed.2022.10.001_bib0870","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/09273948.2013.855799","article-title":"The Manchester Uveitis Clinic: the first 3000\u00a0patients--epidemiology and casemix","volume":"23","author":"Jones","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2022.10.001_bib0875","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000321947","article-title":"The eye as a common site for the early clinical manifestation of sarcoidosis","volume":"46","author":"Heiligenhaus","year":"2011","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.revmed.2022.10.001_bib0880","doi-asserted-by":"crossref","first-page":"802","DOI":"10.5301\/EJO.2011.6417","article-title":"Visual outcome in ocular sarcoidosis: retrospective evaluation of risk factors","volume":"21","author":"Miserocchi","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0885","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ophtha.2009.07.025","article-title":"Hypopyon in patients with uveitis","volume":"117","author":"Zaidi","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2022.10.001_bib0890","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s10384-012-0158-z","article-title":"The 2009\u00a0prospective multi-center epidemiologic survey of uveitis in Japan","volume":"56","author":"Ohguro","year":"2012","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0895","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/bjo.65.5.348","article-title":"Fundus changes in histologically confirmed sarcoidosis","volume":"65","author":"Spalton","year":"1981","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0900","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/0002-9394(78)90184-8","article-title":"Sarcoidosis and its ophthalmic manifestations","volume":"86","author":"Obenauf","year":"1978","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0905","doi-asserted-by":"crossref","first-page":"e171845","DOI":"10.1001\/jamaophthalmol.2017.1845","article-title":"\u201cCandle Wax Dripping\u201d lesions in sarcoidosis","volume":"135","author":"Lezrek","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0910","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jcjo.2021.03.001","article-title":"Clinical features, visual outcome, and poor prognostic factors in occlusive retinal vasculitis","volume":"57","author":"Lin","year":"2022","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0915","first-page":"1801","article-title":"Retinal vascularization in sarcoidosis","volume":"29","author":"Fajnkuchen","year":"2000","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2022.10.001_bib0920","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.autrev.2017.10.010","article-title":"Uveitis: diagnostic work-up. A literature review and recommendations from an expert committee","volume":"16","author":"S\u00e8ve","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2022.10.001_bib0925","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.revmed.2017.09.007","article-title":"Ocular sarcoidosis: what the internist should know?","volume":"39","author":"S\u00e8ve","year":"2018","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2022.10.001_bib0930","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-0037-1602382","article-title":"Ocular involvement in sarcoidosis","volume":"38","author":"Groen","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2022.10.001_bib0935","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08820538.2016.1206576","article-title":"Clinical manifestations, complications and treatment of ocular sarcoidosis: correlation between visual efficiency and macular edema as seen on optical coherence tomography","volume":"14","author":"Paovic","year":"2016","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0940","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1442-9071.2003.00666.x","article-title":"Visual loss in sarcoid-related uveitis","volume":"31","author":"Lobo","year":"2003","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0945","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/eye.1997.77","article-title":"Clinical diagnosis of ocular sarcoidosis","volume":"11","author":"Stavrou","year":"1997","journal-title":"Eye"},{"issue":"5","key":"10.1016\/j.revmed.2022.10.001_bib0950","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10384-022-00927-y","article-title":"Clinical features of ocular sarcoidosis: severe, refractory, and prolonged inflammation","volume":"66","author":"Suzuki","year":"2022","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0955","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.autrev.2014.01.035","article-title":"Diagnostic criteria for sarcoidosis","volume":"13","author":"Heinle","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2022.10.001_bib0960","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1726-4901(09)70311-9","article-title":"Conjunctival biopsy in sarcoidosis","volume":"69","author":"Chung","year":"2006","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.revmed.2022.10.001_bib0965","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bjo.74.8.469","article-title":"Conjunctival biopsy in the diagnosis of sarcoidosis","volume":"74","author":"Spaide","year":"1990","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib0970","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1136\/bmj.2.4949.1180","article-title":"Conjunctival biopsy in sarcoidosis","volume":"2","author":"Crick","year":"1955","journal-title":"Br Med J"},{"key":"10.1016\/j.revmed.2022.10.001_bib0975","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0002-9343(59)90242-6","article-title":"Ocular sarcoidosis","volume":"26","author":"James","year":"1959","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2022.10.001_bib0980","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/09273940902818861","article-title":"International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS)","volume":"17","author":"Herbort","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2022.10.001_bib0985","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ophtha.2017.07.006","article-title":"Distinguishing features of ocular sarcoidosis in an international cohort of uveitis patients","volume":"125","author":"Acharya","year":"2018","journal-title":"Ophthalmology"},{"issue":"7\u20138","key":"10.1016\/j.revmed.2022.10.001_bib0990","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1080\/09273948.2020.1758159","article-title":"A Validation Study of the Revised Diagnostic Criteria from the International Workshop on Ocular Sarcoidosis at a Single Institute in Japan","volume":"29","author":"Handa-Miyauchi","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.revmed.2022.10.001_bib0995","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2020-000663","article-title":"Role of interferon gamma release assay in the diagnosis and management of Mycobacterium tuberculosis-associated uveitis: a review","volume":"6","author":"Rahman","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib1000","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.revmed.2020.09.005","article-title":"Observational study of QuantiFERON\u00ae management for ocular tuberculosis diagnosis: Analysis of 244\u00a0consecutive tests","volume":"42","author":"Amara","year":"2021","journal-title":"Rev Med Interne"},{"issue":"6","key":"10.1016\/j.revmed.2022.10.001_bib1005","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3109\/09273948.2015.1063669","article-title":"Frequency of IWOS suggestive ocular signs in Slovenian uveitis patients with confirmed pulmonary sarcoidosis","volume":"24","author":"Fakin","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2022.10.001_bib1010","first-page":"1","article-title":"The role of screening for asymptomatic ocular inflammation in sarcoidosis","volume":"22","author":"Lee","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2022.10.001_bib1015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ajo.2018.07.010","article-title":"Serum angiotensin-converting enzyme has a high negative predictive value in the investigation for systemic sarcoidosis","volume":"194","author":"Niederer","year":"2018","journal-title":"Am J Ophthalmic"},{"key":"10.1016\/j.revmed.2022.10.001_bib1020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.autrev.2017.10.018","article-title":"Contribution of diagnostic tests for the etiological assessment of uveitis, data from the ULISSE study (Uveitis: Clinical and medicoeconomic evaluation of a standardized strategy of the etiological diagnosis)","volume":"17","author":"Grumet","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2022.10.001_bib1025","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archophthalmol.2011.52","article-title":"Clinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosis","volume":"129","author":"Birnbaum","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib1030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10384-020-00793-6","article-title":"Validation of systemic parameters for the diagnosis of ocular sarcoidosis","volume":"65","author":"Suzuki","year":"2021","journal-title":"Jpn J Ophthalmol"},{"issue":"11","key":"10.1016\/j.revmed.2022.10.001_bib1035","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1136\/bjophthalmol-2020-317354","article-title":"Recommendations for the management of ocular sarcoidosis from the International Workshop on Ocular Sarcoidosis","volume":"105","author":"Takase","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib1040","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/bjophthalmol-2015-307455","article-title":"Lymphopenia as a predictor of sarcoidosis in patients with uveitis","volume":"100","author":"Jones","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib1045","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/bjophthalmol-2018-313212","article-title":"Lymphopaenia as a predictor of sarcoidosis in patients with a first episode of uveitis","volume":"103","author":"Groen-Hakan","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.revmed.2022.10.001_bib1050","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1136\/bjophthalmol-2020-316563","article-title":"Diagnostic value of lymphopaenia and elevated serum ACE in patients with uveitis","volume":"105","author":"Cotte","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib1055","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1183\/09031936.01.99104501","article-title":"Significance of lymphocytosis in bronchoalveolar lavage in suspected ocular sarcoidosis","volume":"18","author":"Takahashi","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2022.10.001_bib1060","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.autrev.2017.03.006","article-title":"Relevance of diagnostic investigations in patients with uveitis: retrospective cohort study on 300\u00a0patients","volume":"16","author":"Hadjadj","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2022.10.001_bib1065","doi-asserted-by":"crossref","first-page":"e5531","DOI":"10.1097\/MD.0000000000005531","article-title":"Vitreous lavage fluid and bronchoalveolar lavage fluid have equal diagnostic value in sarcoidosis","volume":"95","author":"Maruyama","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2022.10.001_bib1070","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.ophtha.2012.05.033","article-title":"The CD4\/CD8\u00a0ratio in vitreous fluid is of high diagnostic value in sarcoidosis","volume":"119","author":"Kojima","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2022.10.001_bib1075","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1136\/bjophthalmol-2018-313133","article-title":"18F-fluorodeoxyglucose positron emission tomography is useful for the diagnosis of intraocular sarcoidosis in patients with a normal CT scan","volume":"103","author":"Chauvelot","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib1080","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/bjophthalmol-2011-300129","article-title":"Minor salivary gland biopsy in diagnosing ocular sarcoidosis","volume":"95","author":"Blaise","year":"2011","journal-title":"Br J Ophtalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib1085","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00417-012-2178-2","article-title":"Ocular sarcoidosis: when should labial salivary gland biopsy be performed?","volume":"251","author":"Bernard","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.revmed.2022.10.001_bib1090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.revmed.2015.07.009","article-title":"[Prevalence of granulomatous lesions in minor salivary gland biopsy in a case series of 65\u00a0patients with tuberculosis]","volume":"37","author":"Delcey","year":"2016","journal-title":"Rev Med Interne"},{"issue":"6","key":"10.1016\/j.revmed.2022.10.001_bib1095","doi-asserted-by":"crossref","first-page":"200479","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2022.10.001_bib1100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jfo.2016.11.013","article-title":"[Treatment of macular edema: comparison of efficacy and tolerability of subconjunctival triamcinolone injections, sub-tenon's triamcinolone injections and intravitreal dexamethasone implant]","volume":"40","author":"Carbonni\u00e8re","year":"2017","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib1105","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jfo.2014.04.010","article-title":"Efficacit\u00e9 et tol\u00e9rance des injections sous-conjonctivales de triamcinolone dans la prise en charge des \u0153d\u00e8mes maculaires uv\u00e9itiques\u00a0: \u00e9tude r\u00e9trospective sur trente et un cas","volume":"37","author":"Bleriot","year":"2014","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib1110","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib1115","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.ajo.2014.09.003","article-title":"Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency","volume":"158","author":"Zarranz-Ventura","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib1120","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.ophtha.2014.02.003","article-title":"Treatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitis","volume":"121","author":"Tomkins-Netzer","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2022.10.001_bib1125","first-page":"601","article-title":"[Efficacy of a dexamethasone implant for the treatment of refractory cystoid macular oedema in non-infectious uveitis]","volume":"233","author":"Breitbach","year":"2016","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.revmed.2022.10.001_bib1130","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1097\/IAE.0000000000000515","article-title":"Efficacy and safety of dexamethasone intravitreal implant for persistent uveitic cystoid macular edema","volume":"35","author":"Khurana","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.revmed.2022.10.001_bib1135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000362178","article-title":"Long-term outcome of an intravitreal dexamethasone implant for the treatment of noninfectious uveitic macular edema","volume":"232","author":"Habot-Wilner","year":"2014","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.revmed.2022.10.001_bib1140","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s12325-019-00989-4","article-title":"Intravitreal dexamethasone implant for treatment of sarcoidosis-related uveitis","volume":"36","author":"Kim","year":"2019","journal-title":"Adv Ther"},{"key":"10.1016\/j.revmed.2022.10.001_bib1145","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ophtha.2017.11.017","article-title":"Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative","volume":"125","author":"Dick","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2022.10.001_bib1150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/09273948.2011.646382","article-title":"High-dose intravenous corticosteroids for ocular inflammatory diseases","volume":"20","author":"Charkoudian","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"issue":"Pt 6","key":"10.1016\/j.revmed.2022.10.001_bib1155","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/eye.1999.221","article-title":"The ocular and systemic prognosis of patients presenting with sarcoid uveitis","volume":"13","author":"Edelsten","year":"1999","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.revmed.2022.10.001_bib1160","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0161-6420(99)90011-8","article-title":"Methotrexate treatment for sarcoid-associated panuveitis","volume":"106","author":"Dev","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2022.10.001_bib1165","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/thx.54.8.742","article-title":"A clinical approach to the use of methotrexate for sarcoidosis","volume":"54","author":"Baughman","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.revmed.2022.10.001_bib1170","first-page":"26","article-title":"Management of ocular sarcoidosis","volume":"29","author":"Baughman","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2022.10.001_bib1175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/09273940902862992","article-title":"Mycophenolate mofetil therapy for sarcoidosis-associated uveitis","volume":"17","author":"Bhat","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"issue":"Hors S\u00e9rie","key":"10.1016\/j.revmed.2022.10.001_bib1180","first-page":"A1","article-title":"Effet b\u00e9n\u00e9fique du traitement immunosuppresseur dans les uv\u00e9ites non-ant\u00e9rieures de la sarco\u00efdose","volume":"43","author":"Leclercq","year":"2022","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2022.10.001_bib1185","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/25785826.2019.1678961","article-title":"Current standardized therapeutic approach for uveitis in Japan","volume":"42","author":"Maruyama","year":"2019","journal-title":"Immunol Med"},{"key":"10.1016\/j.revmed.2022.10.001_bib1190","first-page":"43","article-title":"Leflunomide for chronic sarcoidosis","volume":"21","author":"Baughman","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"hors s\u00e9rie","key":"10.1016\/j.revmed.2022.10.001_bib1195","first-page":"A1","article-title":"L\u2019Hydroxychloroquine\u00a0: un traitement d\u2019\u00e9pargne cortisonique dans l\u2019uv\u00e9ite sarco\u00efdosique","volume":"42","author":"Bert","year":"2021","journal-title":"Rev M\u00e9d Interne"},{"key":"10.1016\/j.revmed.2022.10.001_bib1200","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2022.10.001_bib1205","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","article-title":"Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3\u00a0trial","volume":"388","author":"Nguyen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2022.10.001_bib1210","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ophtha.2017.12.039","article-title":"Safety and efficacy of adalimumab in patients with noninfectious uveitis in an ongoing open-label study: VISUAL III","volume":"125","author":"Suhler","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2022.10.001_bib1215","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/art.39667","article-title":"Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: a multicenter study from the French uveitis network","volume":"68","author":"Vallet","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.revmed.2022.10.001_bib1220","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ajo.2022.02.002","article-title":"Lower relapses rate with infliximab versus adalimumab in sight-threatening uveitis: a multicenter study of 330\u00a0patients","volume":"238","author":"Maalouf","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.revmed.2022.10.001_bib1225","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0012-3692(15)50471-6","article-title":"Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial","volume":"128","author":"Baughman","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2022.10.001_bib1230","first-page":"167","article-title":"Certolizumab Pegol, a new anti-TNF-\u03b1 in the armamentarium against ocular inflammation","volume":"24","author":"Lloren\u00e7","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2022.10.001_bib1235","first-page":"680","article-title":"Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis","volume":"37","author":"Tosi","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2022.10.001_bib1240","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.semarthrit.2017.03.005","article-title":"Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: a multicenter study of 132\u00a0patients","volume":"47","author":"Jamilloux","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2022.10.001_bib1245","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00417-011-1844-0","article-title":"Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis","volume":"250","author":"Erckens","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.revmed.2022.10.001_bib1250","first-page":"26","article-title":"Management of ocular sarcoidosis","volume":"29","author":"Baughman","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2022.10.001_bib1255","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/09273948.2019.1605452","article-title":"Development of vitreoretinal lymphoma in a patient with sarcoid uveitis","volume":"28","author":"Wartique","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"10.1016\/j.revmed.2022.10.001_bib1260","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jbspin.2015.06.002","article-title":"Uveitis in adults: what do rheumatologists need to know?","volume":"82","author":"S\u00e8ve","year":"2015","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.revmed.2022.10.001_bib1265","article-title":"Therapeutic drug monitoring guides the management of patients with chronic non-infectious uveitis treated with adalimumab: a retrospective study","author":"Sejournet","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib1270","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2147\/TCRM.S192922","article-title":"Refractory sarcoidosis: a review","volume":"16","author":"El Jammal","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.revmed.2022.10.001_bib1275","first-page":"173","article-title":"Biotherapies in uveitis","volume":"238","author":"Leclercq","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.revmed.2022.10.001_bib1280","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/09273948.2012.762982","article-title":"Successful treatment of ocular sarcoidosis with rituximab","volume":"21","author":"Beccastrini","year":"2013","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2022.10.001_bib1285","first-page":"1613","article-title":"Rituximab for refractory granulomatous eye disease","volume":"6","author":"Lower","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib1290","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ajo.2017.08.019","article-title":"Primary (Month-6) outcomes of the STOP-uveitis study: evaluating the safety, tolerability, and efficacy of tocilizumab in patients with noninfectious uveitis","volume":"183","author":"Sepah","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib1295","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/09273948.2015.1099680","article-title":"Tocilizumab in uveitic macular edema refractory to previous immunomodulatory treatment","volume":"25","author":"Deuter","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2022.10.001_bib1300","doi-asserted-by":"crossref","first-page":"e400","DOI":"10.1111\/aos.13015","article-title":"Outcome of tocilizumab treatment in refractory ocular inflammatory diseases","volume":"94","author":"Silpa-Archa","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.revmed.2022.10.001_bib1305","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00408-021-00436-8","article-title":"Tofacitinib as a steroid-sparing therapy in pulmonary sarcoidosis, an open-label prospective proof-of-concept study","volume":"199","author":"Friedman","year":"2021","journal-title":"Lung"},{"key":"10.1016\/j.revmed.2022.10.001_bib1310","doi-asserted-by":"crossref","first-page":"225","DOI":"10.55563\/clinexprheumatol\/3gymd4","article-title":"Resolution of ocular and mediastinal sarcoidosis after Janus kinase inhibitor therapy for concomitant rheumatoid arthritis","volume":"39","author":"Sejournet","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2022.10.001_bib1315","article-title":"Protocole national de diagnostic et de soins sur les uv\u00e9ites chroniques non infectieuses de l\u2019enfant et de l\u2019adulte","author":"Quartier-dit-mairie","year":"2020","journal-title":"PNDS"},{"issue":"5","key":"10.1016\/j.revmed.2022.10.001_bib0660","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MCP.0000000000000906","article-title":"Hit-hard and early versus step-up treatment in severe sarcoidosis","volume":"28","author":"Vorselaars","year":"2022","journal-title":"Curr Opin Pulm Med"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866322006695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866322006695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:46:15Z","timestamp":1759337175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866322006695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":132,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0248866322006695"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2022.10.001","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uv\u00e9ites\u00a0sarco\u00efdosiques\u00a0: regards crois\u00e9s de l\u2019ophtalmologiste et de l\u2019interniste","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2022.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}